Ogorek Anthony Joseph’s Organon & Co OGN Stock Holding History

Ogorek Anthony Joseph’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-108	Closed	-$1K	–	680
2025 Q3	$1K	Buy	108 +65	+151%	+$638	﹤0.01%	626
2025 Q2	$0	Buy	+43	New	+$443	﹤0.01%	674
2022 Q1	–	Sell	-5	Closed	–	–	265
2021 Q4	$0	Hold	5	–	–	﹤0.01%	248
2021 Q3	$0	Hold	5	–	–	﹤0.01%	232
2021 Q2	$0	Buy	+5	New	+$165	﹤0.01%	206

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

KBG

Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Ogorek Anthony Joseph's OGN Position: Q4 2025 in Review

Ogorek Anthony Joseph sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 108 shares — an estimated $1K sold.

Ogorek Anthony Joseph first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $1K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

Ogorek Anthony Joseph reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
Ogorek Anthony Joseph sold 108 Organon & Co shares in Q4 2025, an estimated $1K.
Ogorek Anthony Joseph first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
Ogorek Anthony Joseph's Organon & Co position peaked at $1K in Q3 2025.
634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Ogorek Anthony Joseph's 13F filing for Q4 2025, filed 23 Jan 2026.